Analysts Showing Optimistic Trends For OncoCyte Corporation (OCX)


OncoCyte Corporation (OCX) will report its next earnings on Aug 14 AMC. The company reported the earnings of $-0.12/Share in the last quarter where the estimated EPS by analysts was $-0.12/share.

Many analysts are providing their Estimated Earnings analysis for OncoCyte Corporation and for the current quarter 4 analysts have projected that the stock could give an Average Earnings estimate of $-0.09/share. These analysts have also projected a Low Estimate of $-0.1/share and a High Estimate of $-0.09/share.

Some buy side analysts are also providing their Analysis on OncoCyte Corporation, where 1 analysts have rated the stock as Strong buy, 0 analysts have given a Buy signal, 0 said it’s a HOLD, and 0 analysts rated the stock as Sell. (These Recommendations are for the Current Month Only reported by Yahoo Finance.)

When it comes to the Analysis of a Stock, Price Target plays a vital role. Analysts reported that the Price Target for OncoCyte Corporation might touch $7.75 high while the Average Price Target and Low price Target is $4.42 and $2 respectively.

The Relative Volume of the company is 39.91 and Average Volume (3 months) is 60.51 million. The company’s P/E (price to earnings) ratio is 0 and Forward P/E ratio of 0.

The company shows its Return on Assets (ROA) value of -141.4%. The Return on Equity (ROE) value stands at -272.2%.

While looking at the Stock’s Performance, OncoCyte Corporation currently shows a Weekly Performance of 35.29%, where Monthly Performance is 25.45%, Quarterly performance is 56.82%, 6 Months performance is -18.82% and yearly performance percentage is -30.3%. Year to Date performance value (YTD perf) value is -25.81%. The Stock currently has a Weekly Volatility of 15.95% and Monthly Volatility of 15.01%.